Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
Explore this paper's citation graph
Summary
17,187 patients entering 417 hospitals up to 24 h after the onset of suspected acute myocardial infarction were randomized, with placebo control, between a 1 h intravenous infusion of streptokinase and 1 month of 160 mg/day enteric-coated aspirin.
- Type
- article
- Published
- 1988-12-01
- Cited by
- 2,708
- References
- 0
- OpenAlex
- https://openalex.org/W3111702274
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:23547061
Keywords
Medicine, Aspirin, Myocardial infarction, Streptokinase, Randomized controlled trial
References
No references recorded for this paper.
Cited by
- Using statewide audit and feedback to improve hospital care in West Virginia.
- Eicosanoids, other fatty acid metabolites and the cardiovascular system: are the present antithrombotic approaches rational?
- Pharmacological Prevention of Reperfusion Injury in Acute Myocardial Infarction
- The variable extent of jeopardized myocardium in patients with single vessel coronary artery disease: quantification by thallium-201 single photon emission computed tomography.
- Tissue plasminogen activator: why the backlash?
- Serial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction: efficacy for noninvasive assessment of thrombolytic therapy.
- Coronary angioplasty as primary therapy for acute myocardial infarction 6 to 48 hours after symptom onset: report of an initial experience.
- After coronary thrombolysis and reperfusion, what next?
- Mortality as an Outcome in Sepsis Trials
- Have We Reached the Limit with Thrombolytic Therapy?
- Gender differences in anticoagulation and antithrombotic therapy.
- Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease.
- How reliable are clinical trials? The importance of the criteria for early termination.
- Acute myocardial infarction management flowsheet and performance.
- Heparin and Streptokinase
- Current medical therapy for advanced heart failure.
- Antithrombotic agents in coronary artery disease.
- Effects of aspirin treatment on survival in non-insulin-dependent diabetic patients with coronary artery disease. Israeli Bezafibrate Infarction Prevention Study Group.
- Therapiestrategien beim akuten Koronarsyndrom und nach koronaren Interventionen
- Risk factors of stroke after percutaneous transluminal coronary angioplasty
Related papers
- The effect of streptokinase on chest pain in acute myocardial infarction
- The Effect of Streptokinase on Return to Work 18 Months After a First Myocardial Infarction
- Streptokinase for the treatment of acute myocardial infarction: a brief review of randomized trials.
- Acute myocardial infarction and peripheral streptokinase and postthrombolytic course in patients with acute myocardial infarction treated with intravenous streptokinase
- Review of clinical studies of thrombolytic agents in acute myocardial infarction.
- Intravenous streptokinase in acute myocardial infarction (I.S.A.M.) trial: serial evaluation of left ventricular function up to 3 years after infarction estimated by radionuclide ventriculography. I.S.A.M. Study Group.
- Normal coronary myocardial infarct is innocent or guilty? A case of ventricular septal rupture secondary to normal coronary myocardial infarction.